Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 448.8B | 335.9B | - | - | 21.68 | 1.34 | 12.90% | 18.65% |
CI | 91.1B | 183.0B | - | - | 13.64 | 1.92 | 3.34% | 24.58% |
HUM | 65.7B | 95.6B | - | - | 23.41 | 0.71 | 10.74% | 2.64% |
CNC | 34.6B | 146.3B | - | - | 23.33 | 0.24 | 9.81% | -0.94% |
MID-CAP | ||||||||
LHCG | 5.2B | 2.3B | - | - | 86.23 | 2.28 | 2.85% | -58.05% |
HQY | 4.7B | 861.7M | - | - | -178.64 | 5.42 | 13.90% | 40.97% |
AMN | 3.9B | 4.8B | - | - | 10.12 | 0.8 | 3.57% | -4.88% |
CRVL | 3.4B | 704.5M | - | - | 49.59 | 4.78 | 13.56% | 10.15% |
PDCO | 2.6B | 6.4B | - | - | 13.26 | 0.41 | -0.52% | 16.73% |
SMALL-CAP | ||||||||
RDNT | 1.7B | 1.5B | - | - | -126.07 | 1.14 | 10.24% | -173.11% |
ADUS | 1.4B | 976.1M | - | - | 28.65 | 1.47 | 10.19% | 12.37% |
BKD | 645.6M | 2.9B | - | - | -3.53 | 0.22 | 7.97% | -101.02% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 1.4% | 183,028 | 180,516 | 180,453 | 179,461 | 177,112 |
S&GA Expenses | 1.8% | 13,425 | 13,186 | 13,365 | 13,310 | 13,050 |
EBITDA | 0.1% | 12,519 | 12,508 | 8,189 | 11,032 | - |
EBITDA Margin | 0.1% | 0.07* | 0.07* | 0.18* | 0.06* | - |
Earnings Before Taxes | 0.6% | 8,405 | 8,353 | 8,337 | 6,905 | 6,818 |
EBT Margin | 0.2% | 0.05* | 0.05* | 0.15* | 0.04* | - |
Interest Expenses | 1.1% | 1,243 | 1,229 | 1,226 | 1,229 | 1,230 |
Net Income | 1.0% | 6,746 | 6,681 | 5,538 | 5,442 | - |
Net Income Margin | 0.9% | 0.04* | 0.04* | 0.12* | 0.03* | - |
Free Cahsflow | -20.1% | 8,656 | 10,832 | 9,668 | 8,128 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | 2.8% | 147,976 | 143,932 | 144,209 | 152,630 | 152,610 |
Current Assets | 6.3% | 32,027 | 30,120 | 30,170 | 37,422 | 35,393 |
Cash Equivalents | 34.9% | 7,989 | 5,924 | 7,079 | 4,421 | 4,424 |
Inventory | -11.8% | 4,211 | 4,777 | 4,017 | 3,781 | 3,500 |
Goodwill | 0% | 45,811 | 45,811 | 45,807 | 45,810 | 45,804 |
Liabilities | 4.4% | 103,380 | 98,981 | 99,076 | 106,663 | 106,446 |
Current Liabilities | 8.5% | 44,727 | 41,229 | 41,115 | 45,218 | 43,662 |
Long Term Debt | 3.6% | 29,124 | 28,100 | 28,090 | 30,984 | 31,013 |
Shareholder's Equity | -0.8% | 44,518 | 44,872 | 45,041 | 45,922 | 46,109 |
Retained Earnings | 2.6% | 38,841 | 37,874 | 37,041 | 34,626 | 33,420 |
Additional Paid-In Capital | 0.3% | 30,332 | 30,233 | 29,395 | 29,930 | 29,736 |
Minority Interest | 23.1% | 16.00 | 13.00 | 42.00 | 30.00 | 22.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | 34.6% | 11,654 | 8,656 | 10,832 | 9,668 | 8,128 |
Cashflow From Investing | -85.8% | 439 | 3,098 | 3,837 | -1,319 | -3,218 |
Cashflow From Financing | 19.0% | -9,106 | -11,240 | -10,975 | -7,186 | -6,332 |
Buy Backs | -5.3% | 7,201 | 7,607 | 7,295 | 6,406 | 6,316 |
null%
null%
null%
Y-axis is the maximum loss one would have experienced if Cigna was unfortunately bought at previous high price.
FIve years rolling returns for Cigna.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-26 | ProShare Advisors LLC | added | 11.58 | -2,215,320 | 13,667,800 | 0.04% |
2023-05-25 | Brandywine Global Investment Management, LLC | added | 183 | 99,677,800 | 183,856,000 | 0.74% |
2023-05-25 | Empower Advisory Group, LLC | new | - | 1,064,240 | 1,064,240 | -% |
2023-05-24 | Old North State Trust, LLC | unchanged | - | -2,000 | 6,000 | -% |
2023-05-23 | Toroso Investments, LLC | added | 70.44 | 1,390,000 | 5,814,000 | 0.10% |
2023-05-23 | 3Chopt Investment Partners, LLC | new | - | 2,536,200 | 2,536,200 | 1.35% |
2023-05-23 | Brookfield Corp /ON/ | added | 2.84 | -3,875,990 | 14,858,300 | 0.06% |
2023-05-23 | Front Row Advisors LLC | reduced | -16.84 | -11,000 | 20,000 | 0.01% |
2023-05-22 | AMERIPRISE FINANCIAL INC | added | 22.73 | -62,839,300 | 1,110,600,000 | 0.36% |
2023-05-22 | American Trust | reduced | -72.95 | -913,348 | 240,709 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | dodge & cox | 3.8% | 11,548,557 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 4.5% | 13,656,608 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G | |
Feb 09, 2023 | vanguard group inc | 8.37% | 25,583,766 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 9.0% | 27,469,496 | SC 13G | |
Feb 14, 2022 | dodge & cox | 5.3% | 17,484,197 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 5.4% | 17,961,332 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 7.88% | 26,120,848 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 8.9% | 29,587,276 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
May 24, 2023 | 4 | Insider Trading | |
May 10, 2023 | 4 | Insider Trading | |
May 05, 2023 | 10-Q | Quarterly Report | |
May 05, 2023 | 8-K | Current Report | |
May 03, 2023 | 4 | Insider Trading | |
May 01, 2023 | 144 | Notice of Insider Sale Intent | |
May 01, 2023 | 8-K | Current Report | |
Apr 28, 2023 | 8-K | Current Report | |
Apr 28, 2023 | 4 | Insider Trading | |
Apr 28, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-05-22 | Agoglia Hoeltzel Mary T | sold | -128,374 | 254 | -503 | svp tax & chief acct. officer |
2023-05-08 | Palmer Eric P | gifted | - | - | 390 | president & ceo, evernorth |
2023-05-08 | Palmer Eric P | gifted | - | - | -390 | president & ceo, evernorth |
2023-05-01 | ZARCONE DONNA F | sold | -191,741 | 253 | -757 | - |
2023-04-26 | McClellan Mark B. | acquired | - | - | 765 | - |
2023-04-26 | MAZZARELLA KATHLEEN M | acquired | - | - | 765 | - |
2023-04-26 | DeLaney William J III | acquired | - | - | 765 | - |
2023-04-26 | Granger Elder | acquired | - | - | 765 | - |
2023-04-26 | Hathi Neesha | acquired | - | - | 765 | - |
2023-04-26 | Kurian George | acquired | - | - | 765 | - |
Consolidated Statements of Income - USD ($) $ in Millions | 3 Months Ended | ||||
---|---|---|---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | [1] | |||
Revenues | |||||
Premiums | $ 11,025 | $ 10,356 | |||
Net investment income | 277 | 414 | |||
TOTAL REVENUES | 46,517 | 44,006 | |||
Benefits and expenses | |||||
Pharmacy and other service costs | 31,459 | 29,813 | |||
Medical costs and other benefit expenses | 9,046 | 8,272 | |||
Selling, general and administrative expenses | 3,538 | 3,275 | |||
Amortization of acquired intangible assets | 459 | 458 | |||
TOTAL BENEFITS AND EXPENSES | 44,502 | 41,818 | |||
Income from operations | 2,015 | 2,188 | |||
Interest expense and other | (358) | (299) | |||
Net realized investment losses | (56) | (322) | |||
Income before income taxes | 1,601 | 1,567 | |||
TOTAL INCOME TAXES | 295 | 355 | |||
Net income | 1,306 | 1,212 | |||
Less: Net income attributable to noncontrolling interests | 39 | 15 | |||
SHAREHOLDERS' NET INCOME | $ 1,267 | $ 1,197 | |||
Shareholders' net income per share | |||||
Basic (in dollars per share) | $ 4.28 | $ 3.76 | |||
Diluted (in dollars per share) | $ 4.24 | $ 3.73 | |||
Pharmacy revenues | |||||
Revenues | |||||
Revenues | $ 32,144 | $ 30,697 | |||
Fees and other revenues | |||||
Revenues | |||||
Revenues | $ 3,071 | $ 2,539 | |||
|
Consolidated Balance Sheets - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 | [1] | ||||||
---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Cash and cash equivalents | $ 7,935 | $ 5,924 | |||||||
Investments | 914 | 905 | |||||||
Accounts receivable, net | 17,704 | 17,218 | |||||||
Inventories | 4,211 | 4,777 | |||||||
Other current assets | 1,263 | 1,298 | |||||||
Total current assets | 32,027 | 30,122 | |||||||
Long-term investments | 19,010 | 16,288 | |||||||
Reinsurance recoverables | 5,286 | 5,416 | |||||||
Property and equipment | 3,837 | 3,774 | |||||||
Goodwill | 45,811 | 45,811 | |||||||
Other intangible assets | 32,102 | 32,492 | |||||||
Other assets | 2,563 | 2,704 | |||||||
Separate account assets | 7,340 | 7,278 | |||||||
TOTAL ASSETS | 147,976 | 143,885 | |||||||
Liabilities | |||||||||
Current insurance and contractholder liabilities | 7,166 | 5,409 | |||||||
Pharmacy and other service costs payable | 17,609 | 17,070 | |||||||
Accounts payable | 7,360 | 7,775 | |||||||
Accrued expenses and other liabilities | 9,174 | 7,978 | |||||||
Short-term debt | 3,418 | 2,993 | |||||||
Total current liabilities | 44,727 | 41,225 | |||||||
Non-current insurance and contractholder liabilities | 11,790 | 11,976 | |||||||
Deferred tax liabilities, net | 7,707 | 7,786 | |||||||
Other non-current liabilities | 2,692 | 2,766 | |||||||
Long-term debt | 29,124 | 28,100 | |||||||
Separate account liabilities | 7,340 | 7,278 | |||||||
TOTAL LIABILITIES | 103,380 | 99,131 | |||||||
Contingencies — Note 16 | |||||||||
Redeemable noncontrolling interests | 78 | 66 | |||||||
Shareholders' equity | |||||||||
Common stock | [2] | 4 | 4 | ||||||
Additional paid-in capital | 30,332 | 30,233 | |||||||
Accumulated other comprehensive loss | (1,769) | (1,658) | |||||||
Retained earnings | 38,841 | 37,940 | |||||||
Less: Treasury stock, at cost | (22,906) | (21,844) | |||||||
TOTAL SHAREHOLDERS' EQUITY | 44,502 | 44,675 | |||||||
Other noncontrolling interests | 16 | 13 | |||||||
Total equity | 44,518 | 44,688 | [3] | ||||||
Total liabilities and equity | $ 147,976 | $ 143,885 | |||||||
|